| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | STARD13 TBC1D3E RAP1GAP TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP36 TBC1D3C TBC1D3B IQGAP1 TBC1D3I TBC1D3G TBC1D3K AGAP1 TBC1D3F | 1.16e-11 | 279 | 120 | 16 | GO:0005096 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | STARD13 TBC1D3E RAP1GAP TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP36 OBSCN TBC1D3C TBC1D3B IQGAP1 CCDC88C ARHGEF3 TBC1D3I TBC1D3G TBC1D3K AGAP1 TBC1D3F | 1.90e-10 | 507 | 120 | 19 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | STARD13 TBC1D3E RAP1GAP TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP36 OBSCN TBC1D3C TBC1D3B IQGAP1 CCDC88C ARHGEF3 TBC1D3I TBC1D3G TBC1D3K AGAP1 TBC1D3F | 1.90e-10 | 507 | 120 | 19 | GO:0030695 |
| GeneOntologyMolecularFunction | enzyme activator activity | STARD13 TBC1D3E RAP1GAP TBC1D3 ERCC6 TBC1D3H TBC1D3L TBC1D3D ARHGAP36 TBC1D3C TBC1D3B IQGAP1 TBC1D3I TBC1D3G TBC1D3K AGAP1 TBC1D3F | 4.01e-07 | 656 | 120 | 17 | GO:0008047 |
| GeneOntologyMolecularFunction | dihydropyrimidinase activity | 4.18e-06 | 6 | 120 | 3 | GO:0004157 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | A2M STARD13 TBC1D3E RAP1GAP TBC1D3 ERCC6 TBC1D3H TBC1D3L TBC1D3D ARHGAP36 OBSCN RENBP TBC1D3C TBC1D3B IQGAP1 CCDC88C ARHGEF3 TBC1D3I TBC1D3G TBC1D3K AGAP1 TBC1D3F | 3.40e-05 | 1418 | 120 | 22 | GO:0030234 |
| GeneOntologyMolecularFunction | structural molecule activity | EPPK1 ANK3 TNC KRT27 KRT28 SPTA1 NUMA1 OBSCN LAMA4 ACTN1 COL24A1 SHANK2 MMRN2 LTBP2 KRT25 RPL17 | 8.66e-05 | 891 | 120 | 16 | GO:0005198 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides | 1.12e-04 | 16 | 120 | 3 | GO:0016812 | |
| GeneOntologyMolecularFunction | molecular function activator activity | STARD13 TBC1D3E RAP1GAP TBC1D3 ERCC6 TBC1D3H TBC1D3L INCENP TBC1D3D ARHGAP36 TBC1D3C TBC1D3B IQGAP1 TBC1D3I TBC1D3G TBC1D3K AGAP1 TBC1D3F | 4.04e-04 | 1233 | 120 | 18 | GO:0140677 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 6.21e-04 | 28 | 120 | 3 | GO:0051959 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B SCRIB TBC1D3I TBC1D3G TBC1D3K AGAP1 TBC1D3F | 5.89e-14 | 109 | 119 | 13 | GO:0090630 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3E RAP1GAP TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B IQGAP1 SCRIB TBC1D3I TBC1D3G MMUT TBC1D3K AGAP1 EPHA4 TBC1D3F | 9.25e-12 | 335 | 119 | 17 | GO:0043087 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3E RAP1GAP TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B SCRIB TBC1D3I TBC1D3G MMUT TBC1D3K AGAP1 TBC1D3F | 1.12e-11 | 244 | 119 | 15 | GO:0043547 |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | TBC1D3E RAP1GAP TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B DDX11 SCRIB TBC1D3I TBC1D3G MMUT TBC1D3K AGAP1 EPHA4 TBC1D3F | 4.27e-09 | 499 | 119 | 17 | GO:0051345 |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | A2M TBC1D3E RAP1GAP TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B IQGAP1 DDX11 SCRIB TBC1D3I TBC1D3G MMUT TBC1D3K AGAP1 EPHA4 TBC1D3F | 6.51e-07 | 878 | 119 | 19 | GO:0051336 |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | TBC1D3E RAP1GAP TBC1D3 TBC1D3H TBC1D3L ANK3 TBC1D3D SPTA1 TRIM31 TBC1D3C TBC1D3B IQGAP1 DDX11 PLCL2 STK39 SCRIB TBC1D3I TBC1D3G MMUT TBC1D3K AGAP1 EPHA4 TBC1D3F | 6.29e-06 | 1430 | 119 | 23 | GO:0044093 |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase catabolic process | 1.03e-05 | 8 | 119 | 3 | GO:0006208 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | TBC1D3E RAP1GAP TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B IQGAP1 DDX11 SCRIB TBC1D3I TBC1D3G MMUT TBC1D3K AGAP1 EPHA4 TBC1D3F | 2.44e-05 | 1028 | 119 | 18 | GO:0043085 |
| GeneOntologyBiologicalProcess | meiotic spindle midzone assembly | 3.30e-05 | 2 | 119 | 2 | GO:0051257 | |
| GeneOntologyBiologicalProcess | nucleobase catabolic process | 5.13e-05 | 13 | 119 | 3 | GO:0046113 | |
| GeneOntologyBiologicalProcess | regulation of metaphase plate congression | 8.10e-05 | 15 | 119 | 3 | GO:0090235 | |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent cytokinesis | 9.52e-05 | 127 | 119 | 6 | GO:0061640 | |
| GeneOntologyBiologicalProcess | microtubule-based process | ANK3 INCENP LZTFL1 NUMA1 FYCO1 XPO1 KIF20B SPAG5 DNAH1 FSIP2 CCDC88C CEP250 MLH1 FMN2 GAPDHS DNAH8 CDH5 | 1.20e-04 | 1058 | 119 | 17 | GO:0007017 |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase metabolic process | 2.66e-04 | 22 | 119 | 3 | GO:0006206 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | ANK3 INCENP NUMA1 XPO1 SPAG5 DNAH1 FSIP2 CCDC88C CEP250 MLH1 FMN2 DNAH8 CDH5 | 2.67e-04 | 720 | 119 | 13 | GO:0000226 |
| GeneOntologyBiologicalProcess | epithelium development | STARD13 EPPK1 TNC KRT27 KRT28 NUMA1 PDZD7 KDM6B KIF20B ITPK1 IQGAP1 IVL CCDC88C FASN MMRN2 ANKRD24 SCRIB CDH5 KRT25 EPHA4 | 2.71e-04 | 1469 | 119 | 20 | GO:0060429 |
| GeneOntologyCellularComponent | supramolecular fiber | DPYSL2 DPYSL3 EPPK1 ANK3 INCENP KRT27 KRT28 NUMA1 OBSCN ACTN1 KIF20B SPAG5 IQGAP1 DNAH1 SHANK2 FMN2 DNAH8 KRT25 RPL17 | 3.68e-05 | 1179 | 119 | 19 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | DPYSL2 DPYSL3 EPPK1 ANK3 INCENP KRT27 KRT28 NUMA1 OBSCN ACTN1 KIF20B SPAG5 IQGAP1 DNAH1 SHANK2 FMN2 DNAH8 KRT25 RPL17 | 4.04e-05 | 1187 | 119 | 19 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | DPYSL2 DPYSL3 EPPK1 INCENP KRT27 KRT28 NUMA1 ACTN1 KIF20B SPAG5 IQGAP1 DNAH1 SHANK2 FMN2 DNAH8 KRT25 | 5.08e-05 | 899 | 119 | 16 | GO:0099513 |
| GeneOntologyCellularComponent | axon | CNTNAP3B DPYSL2 DPYSL3 RAP1GAP ANK3 TSPOAP1 PRSS12 SPTA1 CNTNAP3 KIF20B IQGAP1 SHANK2 IQCJ-SCHIP1 EPHA4 | 5.47e-04 | 891 | 119 | 14 | GO:0030424 |
| GeneOntologyCellularComponent | cell-cell junction | EPPK1 MYLK ANK3 OBSCN ACTN1 IQGAP1 CCDC88C SCRIB PATJ CDH5 EPHA4 | 5.63e-04 | 591 | 119 | 11 | GO:0005911 |
| Domain | TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 5.45e-13 | 49 | 120 | 10 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.27e-12 | 53 | 120 | 10 | PF00566 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.88e-12 | 55 | 120 | 10 | IPR000195 |
| Domain | TBC_RABGAP | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.88e-12 | 55 | 120 | 10 | PS50086 |
| Domain | Hydantoinase/dihydroPyrase | 5.10e-06 | 6 | 120 | 3 | IPR011778 | |
| Domain | - | 1.41e-05 | 8 | 120 | 3 | 2.30.40.10 | |
| Domain | Amidohydro_1 | 3.00e-05 | 10 | 120 | 3 | PF01979 | |
| Domain | Metal-dep_hydrolase_composite | 3.00e-05 | 10 | 120 | 3 | IPR011059 | |
| Domain | Amidohydro-rel | 4.11e-05 | 11 | 120 | 3 | IPR006680 | |
| Domain | FIBRINOGEN_C_1 | 5.07e-05 | 32 | 120 | 4 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 5.07e-05 | 32 | 120 | 4 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 5.07e-05 | 32 | 120 | 4 | PS51406 | |
| Domain | LAM_G_DOMAIN | 1.01e-04 | 38 | 120 | 4 | PS50025 | |
| Domain | Laminin_G_2 | 1.24e-04 | 40 | 120 | 4 | PF02210 | |
| Domain | PDZ | 3.00e-04 | 141 | 120 | 6 | PF00595 | |
| Domain | PDZ | 3.89e-04 | 148 | 120 | 6 | SM00228 | |
| Domain | - | 4.18e-04 | 150 | 120 | 6 | 2.30.42.10 | |
| Domain | PDZ | 4.33e-04 | 151 | 120 | 6 | PS50106 | |
| Domain | PDZ | 4.49e-04 | 152 | 120 | 6 | IPR001478 | |
| Domain | Metal_Hydrolase | 4.74e-04 | 24 | 120 | 3 | IPR032466 | |
| Domain | Ank_2 | 4.81e-04 | 215 | 120 | 7 | PF12796 | |
| Domain | Laminin_G | 5.26e-04 | 58 | 120 | 4 | IPR001791 | |
| Domain | EFhand_Ca_insen | 6.04e-04 | 6 | 120 | 2 | PF08726 | |
| Domain | EF-hand_Ca_insen | 6.04e-04 | 6 | 120 | 2 | IPR014837 | |
| Domain | Ank | 6.82e-04 | 228 | 120 | 7 | PF00023 | |
| Domain | FBG | 8.37e-04 | 29 | 120 | 3 | SM00186 | |
| Domain | - | 9.25e-04 | 30 | 120 | 3 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 9.25e-04 | 30 | 120 | 3 | IPR014716 | |
| Domain | - | 1.11e-03 | 248 | 120 | 7 | 1.25.40.20 | |
| Domain | 6hp_glycosidase | 1.12e-03 | 8 | 120 | 2 | IPR012341 | |
| Domain | - | 1.12e-03 | 8 | 120 | 2 | 1.50.10.10 | |
| Domain | ANK | 1.19e-03 | 251 | 120 | 7 | SM00248 | |
| Domain | ANK_REPEAT | 1.25e-03 | 253 | 120 | 7 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 1.28e-03 | 254 | 120 | 7 | IPR020683 | |
| Domain | ANK_REP_REGION | 1.28e-03 | 254 | 120 | 7 | PS50297 | |
| Domain | Ankyrin_rpt | 1.53e-03 | 262 | 120 | 7 | IPR002110 | |
| Domain | Keratin_I | 2.83e-03 | 44 | 120 | 3 | IPR002957 | |
| Domain | LamG | 2.83e-03 | 44 | 120 | 3 | SM00282 | |
| Domain | 6-hairpin_glycosidase-like | 3.05e-03 | 13 | 120 | 2 | IPR008928 | |
| Domain | Galactose-bd-like | 3.17e-03 | 94 | 120 | 4 | IPR008979 | |
| Domain | SAM_DOMAIN | 3.29e-03 | 95 | 120 | 4 | PS50105 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.54e-03 | 14 | 120 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.54e-03 | 14 | 120 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.54e-03 | 14 | 120 | 2 | IPR013602 | |
| Domain | DHC_N2 | 3.54e-03 | 14 | 120 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 3.54e-03 | 14 | 120 | 2 | IPR011704 | |
| Domain | MT | 3.54e-03 | 14 | 120 | 2 | PF12777 | |
| Domain | AAA_8 | 3.54e-03 | 14 | 120 | 2 | PF12780 | |
| Domain | AAA_5 | 3.54e-03 | 14 | 120 | 2 | PF07728 | |
| Domain | SAM | 3.55e-03 | 97 | 120 | 4 | IPR001660 | |
| Domain | fn3 | 3.95e-03 | 162 | 120 | 5 | PF00041 | |
| Domain | DHC_fam | 4.07e-03 | 15 | 120 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 4.07e-03 | 15 | 120 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 4.07e-03 | 15 | 120 | 2 | IPR004273 | |
| Domain | Syntaxin/epimorphin_CS | 4.63e-03 | 16 | 120 | 2 | IPR006012 | |
| Domain | SYNTAXIN | 4.63e-03 | 16 | 120 | 2 | PS00914 | |
| Domain | Helicase_C | 5.03e-03 | 107 | 120 | 4 | PF00271 | |
| Domain | HELICc | 5.03e-03 | 107 | 120 | 4 | SM00490 | |
| Domain | Helicase_C | 5.20e-03 | 108 | 120 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 5.37e-03 | 109 | 120 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 5.37e-03 | 109 | 120 | 4 | PS51192 | |
| Domain | DEXDc | 5.37e-03 | 109 | 120 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 5.54e-03 | 110 | 120 | 4 | IPR014001 | |
| Domain | HEAT | 6.17e-03 | 58 | 120 | 3 | IPR000357 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3E TBC1D3 TBC1D3H TBC1D3L DDX52 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K | 1.54e-09 | 99 | 98 | 10 | M46448 |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 1.40e-04 | 15 | 98 | 3 | MM15031 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 1.71e-04 | 16 | 98 | 3 | M8245 | |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 5.67e-28 | 11 | 121 | 11 | 16863688 |
| Pubmed | TRPM6 ANK3 DDX52 STXBP4 PEG3 OBSCN ANKRD49 FCHO2 ANKRD50 AKAP12 SPAG5 ORC4 MFAP3 PLCL2 SMARCC1 FMN2 TMEM131 ARHGEF3 PATJ | 7.07e-09 | 1084 | 121 | 19 | 11544199 | |
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 7.68e-09 | 74 | 121 | 7 | 16625196 | |
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 11771764 | ||
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 17920809 | ||
| Pubmed | The Ulip family phosphoproteins--common and specific properties. | 1.64e-07 | 4 | 121 | 3 | 9652388 | |
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 1.64e-07 | 4 | 121 | 3 | 12359748 | |
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 8406013 | ||
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 10664068 | ||
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 12604796 | ||
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 8471161 | ||
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 8973361 | ||
| Pubmed | DPYSL2 RAP1GAP ANK3 PEG3 ANKRD49 APEH ACTN1 KDM6B IQGAP1 DGLUCY STX18 NECAB3 FMN2 TMEM131 ANKRD24 SCRIB AGAP1 VCPIP1 | 5.10e-07 | 1285 | 121 | 18 | 35914814 | |
| Pubmed | 8.15e-07 | 6 | 121 | 3 | 10956643 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EHBP1 DPYSL2 DPYSL3 STXBP4 NUMA1 DPYSL4 BTAF1 AKAP12 SPAG5 FASN MLH1 SCRIB AKAP1 RPL17 VCPIP1 | 9.33e-07 | 934 | 121 | 15 | 33916271 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | EPPK1 DDX52 NUMA1 IQGAP1 DHX8 FASN STX18 SSU72 SMARCC1 SCRIB DNAH8 RPL17 VCPIP1 | 1.14e-06 | 704 | 121 | 13 | 29955894 |
| Pubmed | EHBP1 ANK3 NUMA1 XPO1 FCHO2 ANKRD50 AKAP12 IQGAP1 FASN NCAPD2 SCRIB PATJ VCPIP1 | 1.21e-06 | 708 | 121 | 13 | 39231216 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | A2M DPYSL2 EPPK1 APEH DPYSL4 TTYH3 ACTN1 XPO1 AKAP12 IQGAP1 IVL FASN NCAPD2 SMARCC1 STK39 SCRIB MMUT RPL17 | 1.24e-06 | 1367 | 121 | 18 | 32687490 |
| Pubmed | CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. | 2.27e-06 | 8 | 121 | 3 | 12134159 | |
| Pubmed | DPYSL2 EPPK1 INCENP DDX52 NUMA1 ACTN1 XPO1 IQGAP1 DHX8 FASN NCAPD2 SMARCC1 | 3.16e-06 | 653 | 121 | 12 | 22586326 | |
| Pubmed | DPYSL2 DPYSL3 ANK3 NUMA1 ACTN1 FASN NCAPD2 SMARCC1 SCRIB PATJ VCPIP1 | 3.67e-06 | 549 | 121 | 11 | 38280479 | |
| Pubmed | 5.04e-06 | 360 | 121 | 9 | 33111431 | ||
| Pubmed | 6.64e-06 | 11 | 121 | 3 | 19210786 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | A2M EPPK1 ERCC6 INCENP DDX52 NUMA1 ACTN1 XPO1 KIF20B IQGAP1 DHX8 FASN SCRIB GAPDHS PATJ RPL17 | 7.80e-06 | 1257 | 121 | 16 | 36526897 |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 8.78e-06 | 208 | 121 | 7 | 33230847 | |
| Pubmed | 8.83e-06 | 12 | 121 | 3 | 15617563 | ||
| Pubmed | DPYSL2 DPYSL3 RAP1GAP ANK3 WFS1 TNC SPTA1 DPYSL4 CNKSR2 ACTN1 XPO1 IQGAP1 FASN SHANK2 AKR1B10 SCRIB RPL17 | 9.76e-06 | 1431 | 121 | 17 | 37142655 | |
| Pubmed | EPPK1 TNC FYCO1 TTYH3 ACTN1 XPO1 AKAP12 IQGAP1 AKR1B10 TMEM131 | 1.11e-05 | 503 | 121 | 10 | 36217030 | |
| Pubmed | DPYSL2 ERCC6 NUMA1 FCHO2 IQGAP1 FASN NCAPD2 TMEM131 STK39 SCRIB | 1.11e-05 | 503 | 121 | 10 | 16964243 | |
| Pubmed | WFS1 FYCO1 ANKRD50 AKAP12 STX18 COG6 FMN2 TMEM131 STX7 AKAP1 | 1.13e-05 | 504 | 121 | 10 | 34432599 | |
| Pubmed | A proteomic snapshot of the human heat shock protein 90 interactome. | 1.16e-05 | 40 | 121 | 4 | 16263121 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 31150793 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 26118640 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 26807827 | ||
| Pubmed | A relative signalling model for the formation of a topographic neural map. | 1.20e-05 | 2 | 121 | 2 | 15483613 | |
| Pubmed | NuMA1 promotes axon initial segment assembly through inhibition of endocytosis. | 1.20e-05 | 2 | 121 | 2 | 31727776 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 26574545 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 37913973 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 22826151 | ||
| Pubmed | 1.75e-05 | 421 | 121 | 9 | 36976175 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | STARD13 DPYSL2 ERCC6 INCENP DDX52 NUMA1 ACTN1 XPO1 KIF20B IQGAP1 FASN NCAPD2 MLH1 SMARCC1 SCRIB RPL17 | 1.93e-05 | 1353 | 121 | 16 | 29467282 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 2.07e-05 | 430 | 121 | 9 | 35044719 | |
| Pubmed | 2.07e-05 | 430 | 121 | 9 | 32581705 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | STARD13 EPPK1 ANK3 SPTA1 NUMA1 FYCO1 ACTN1 SPAG5 IQGAP1 DNAH1 FASN RPL17 | 2.61e-05 | 807 | 121 | 12 | 30575818 |
| Pubmed | 2.62e-05 | 49 | 121 | 4 | 21362503 | ||
| Pubmed | 2.90e-05 | 449 | 121 | 9 | 31732153 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPPK1 OBSCN APEH FYCO1 BTAF1 TTYH3 KDM6B CCDC88C FASN SHANK2 SSU72 BANP NCAPD2 MLLT1 | 3.17e-05 | 1105 | 121 | 14 | 35748872 |
| Pubmed | DPYSL2 ANK3 NUMA1 DPYSL4 CNKSR2 FYCO1 AKAP12 IQGAP1 CCDC88C SHANK2 SMARCC1 SCRIB EPHA4 | 3.24e-05 | 963 | 121 | 13 | 28671696 | |
| Pubmed | Genetic dissection of EphA receptor signaling dynamics during retinotopic mapping. | 3.59e-05 | 3 | 121 | 2 | 21753007 | |
| Pubmed | Diversity of human copy number variation and multicopy genes. | 3.59e-05 | 3 | 121 | 2 | 21030649 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 33591602 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 18471005 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 16874310 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 19522705 | ||
| Pubmed | MUC1 and Polarity Markers INADL and SCRIB Identify Salivary Ductal Cells. | 3.59e-05 | 3 | 121 | 2 | 35259994 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 20470425 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 16965966 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 16190873 | ||
| Pubmed | CRMP2 as a Candidate Target to Interfere with Lung Cancer Cell Migration. | 3.59e-05 | 3 | 121 | 2 | 34680167 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 3.83e-05 | 582 | 121 | 10 | 20467437 | |
| Pubmed | STARD13 MYLK DDX52 SPTA1 NUMA1 ANKRD30B ACTN1 IQGAP1 DDX11 FASN SHANK2 NCAPD2 SMARCC1 MLLT1 DNAH8 EPHA4 | 4.16e-05 | 1442 | 121 | 16 | 35575683 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | DPYSL2 DPYSL3 EPPK1 ANK3 LZTFL1 ACTN1 XPO1 AKAP12 IQGAP1 FASN NCAPD2 PATJ STX7 RPL17 | 4.83e-05 | 1149 | 121 | 14 | 35446349 |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 5.49e-05 | 377 | 121 | 8 | 38117590 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ERCC6 INCENP NUMA1 BTAF1 KIF20B DHX8 FSIP2 ORC4 MLH1 SMARCC1 | 5.52e-05 | 608 | 121 | 10 | 36089195 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 6.01e-05 | 281 | 121 | 7 | 28706196 | |
| Pubmed | 6.06e-05 | 494 | 121 | 9 | 26831064 | ||
| Pubmed | SP3 ERCC6 DDX52 ACTN1 KIF20B IQGAP1 DHX8 ORC4 SHANK2 STX18 NCAPD2 MLH1 MLLT1 PATJ AKAP1 AGAP1 | 6.47e-05 | 1497 | 121 | 16 | 31527615 | |
| Pubmed | 6.48e-05 | 195 | 121 | 6 | 19454010 | ||
| Pubmed | Nuclear Mitotic Apparatus (NuMA) Interacts with and Regulates Astrin at the Mitotic Spindle. | 7.17e-05 | 4 | 121 | 2 | 27462074 | |
| Pubmed | CRMP2 tethers kainate receptor activity to cytoskeleton dynamics during neuronal maturation. | 7.17e-05 | 4 | 121 | 2 | 24227739 | |
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 26147384 | ||
| Pubmed | Amino- and carboxyl-terminal domains of Filamin-A interact with CRMP1 to mediate Sema3A signalling. | 7.17e-05 | 4 | 121 | 2 | 25358863 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 7.87e-05 | 202 | 121 | 6 | 33005030 | |
| Pubmed | A2M RAP1GAP BTAF1 ANKRD50 SPAG5 MLH1 SMARCC1 SCRIB GAPDHS PATJ | 9.57e-05 | 650 | 121 | 10 | 38777146 | |
| Pubmed | 9.74e-05 | 210 | 121 | 6 | 16565220 | ||
| Pubmed | 1.00e-04 | 411 | 121 | 8 | 36652389 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.13e-04 | 135 | 121 | 5 | 28675934 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | WFS1 DDX52 BTAF1 XPO1 SPAG5 IQGAP1 FASN STX18 NCAPD2 SCRIB STX7 VCPIP1 | 1.14e-04 | 942 | 121 | 12 | 31073040 |
| Pubmed | WFS1 DDX52 NUMA1 APEH XPO1 IQGAP1 DHX8 DNAH1 FASN MLH1 SMARCC1 MLLT1 PATJ RPL17 | 1.15e-04 | 1247 | 121 | 14 | 27684187 | |
| Pubmed | 1.19e-04 | 5 | 121 | 2 | 25950943 | ||
| Pubmed | Retinal axon misrouting at the optic chiasm in mice with neural tube closure defects. | 1.19e-04 | 5 | 121 | 2 | 10862153 | |
| Pubmed | 1.19e-04 | 5 | 121 | 2 | 18550753 | ||
| Pubmed | 1.19e-04 | 5 | 121 | 2 | 16611631 | ||
| Pubmed | 1.19e-04 | 5 | 121 | 2 | 17099693 | ||
| Pubmed | 1.19e-04 | 5 | 121 | 2 | 10887087 | ||
| Pubmed | 1.19e-04 | 5 | 121 | 2 | 34048454 | ||
| Pubmed | 1.19e-04 | 5 | 121 | 2 | 28583412 | ||
| Pubmed | 1.26e-04 | 28 | 121 | 3 | 28218627 | ||
| Pubmed | 1.45e-04 | 226 | 121 | 6 | 31452512 | ||
| Pubmed | 1.56e-04 | 560 | 121 | 9 | 35241646 | ||
| Pubmed | 1.63e-04 | 330 | 121 | 7 | 21044950 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.64e-04 | 231 | 121 | 6 | 16452087 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 1.67e-04 | 565 | 121 | 9 | 25468996 | |
| Pubmed | STARD13 EHBP1 DPYSL2 RAP1GAP EPPK1 ANK3 PGGHG TNC LAMA4 CNKSR2 FYCO1 ORC4 STX18 GAPDHS | 1.67e-04 | 1293 | 121 | 14 | 15342556 | |
| Pubmed | 1.74e-04 | 568 | 121 | 9 | 37774976 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 1.76e-04 | 569 | 121 | 9 | 30639242 | |
| Pubmed | An anchored PKA and PDE4 complex regulates subplasmalemmal cAMP dynamics. | 1.78e-04 | 6 | 121 | 2 | 16642035 | |
| Pubmed | 1.78e-04 | 6 | 121 | 2 | 21095589 | ||
| Pubmed | 1.78e-04 | 6 | 121 | 2 | 17626016 | ||
| Pubmed | 1.78e-04 | 6 | 121 | 2 | 19926752 | ||
| Interaction | KRT72 interactions | 5.54e-08 | 59 | 119 | 7 | int:KRT72 | |
| Interaction | FCHO2 interactions | 3.80e-06 | 109 | 119 | 7 | int:FCHO2 | |
| Interaction | KRT86 interactions | 5.39e-06 | 75 | 119 | 6 | int:KRT86 | |
| Interaction | KCNA3 interactions | EHBP1 EPPK1 ANK3 LZTFL1 NUMA1 FYCO1 XPO1 FCHO2 ANKRD50 AKAP12 IQGAP1 CCDC88C FASN NCAPD2 SCRIB PATJ VCPIP1 | 1.42e-05 | 871 | 119 | 17 | int:KCNA3 |
| Interaction | C11orf52 interactions | EHBP1 ANK3 XPO1 FCHO2 ANKRD50 AKAP12 IQGAP1 PLCL2 FMN2 SCRIB | 1.60e-05 | 311 | 119 | 10 | int:C11orf52 |
| Interaction | KRT4 interactions | 3.26e-05 | 62 | 119 | 5 | int:KRT4 | |
| Interaction | DPYS interactions | 4.25e-05 | 12 | 119 | 3 | int:DPYS | |
| Interaction | LRRC57 interactions | 5.25e-05 | 35 | 119 | 4 | int:LRRC57 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D DDX52 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 7.52e-15 | 149 | 121 | 12 | chr17q12 |
| Cytoband | 17q12 | 6.87e-06 | 99 | 121 | 5 | 17q12 | |
| Cytoband | 14q24 | 3.73e-04 | 11 | 121 | 2 | 14q24 | |
| Cytoband | 4q28.1 | 8.07e-04 | 16 | 121 | 2 | 4q28.1 | |
| Cytoband | 17q21.2 | 8.59e-04 | 70 | 121 | 3 | 17q21.2 | |
| Cytoband | 14q32.11 | 9.13e-04 | 17 | 121 | 2 | 14q32.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 1.55e-03 | 316 | 121 | 5 | chr3p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q22 | 1.66e-03 | 88 | 121 | 3 | chr17q22 | |
| Cytoband | 3p21.31 | 2.40e-03 | 100 | 121 | 3 | 3p21.31 | |
| GeneFamily | Ankyrin repeat domain containing | 1.06e-05 | 242 | 79 | 8 | 403 | |
| GeneFamily | PDZ domain containing | 5.36e-05 | 152 | 79 | 6 | 1220 | |
| GeneFamily | Keratins, type I | 2.43e-04 | 28 | 79 | 3 | 608 | |
| GeneFamily | Fibronectin type III domain containing | 6.78e-04 | 160 | 79 | 5 | 555 | |
| GeneFamily | Syntaxins | 2.17e-03 | 16 | 79 | 2 | 818 | |
| GeneFamily | Dyneins, axonemal | 2.46e-03 | 17 | 79 | 2 | 536 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_UP | 3.80e-06 | 200 | 119 | 8 | M3901 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | DPYSL3 ANK3 INCENP KRT27 PRSS12 PEG3 NUMA1 MFAP3 STX18 NCAPD2 MLLT1 LTBP2 KRT25 | 4.24e-06 | 610 | 119 | 13 | M3854 |
| Coexpression | GRUETZMANN_PANCREATIC_CANCER_UP | DPYSL3 RAP1GAP MYLK SPTA1 LAMA4 XPO1 AKAP12 IQGAP1 DHX8 AKAP1 | 5.81e-06 | 359 | 119 | 10 | M15193 |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | DPYSL3 ANK3 INCENP KRT27 PRSS12 PEG3 NUMA1 MFAP3 STX18 NCAPD2 MLLT1 LTBP2 KRT25 | 8.38e-06 | 650 | 119 | 13 | MM1042 |
| Coexpression | AIZARANI_LIVER_C29_MVECS_2 | 1.35e-05 | 313 | 119 | 9 | M39128 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | DPYSL3 ANK3 INCENP KRT27 PRSS12 NUMA1 MFAP3 STX18 MLLT1 LTBP2 CDH5 KRT25 | 2.42e-05 | 615 | 119 | 12 | M8673 |
| Coexpression | NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON | 3.17e-05 | 132 | 119 | 6 | M3434 | |
| Coexpression | GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN | 3.69e-05 | 200 | 119 | 7 | M4889 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | DPYSL3 ANK3 INCENP KRT27 PRSS12 NUMA1 MFAP3 STX18 MLLT1 LTBP2 CDH5 KRT25 | 4.73e-05 | 659 | 119 | 12 | MM1040 |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 5.18e-05 | 211 | 119 | 7 | M12225 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP | INCENP WFS1 STXBP4 PEG3 LAMA4 PDZD7 TTYH3 CCDC88C CEP250 NCAPD2 SMARCC1 STK39 ARHGEF3 EPHA4 | 5.38e-05 | 891 | 119 | 14 | M45033 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | DPYSL3 RAP1GAP MYLK LAMA4 FYCO1 ANGPTL1 SHANK2 MMRN2 LTBP2 ARHGEF3 PATJ AKAP1 EPHA4 | 7.87e-05 | 807 | 119 | 13 | M16651 |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B AKAP1 TBC1D3G TBC1D3K TBC1D3F | 9.65e-11 | 90 | 121 | 10 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L PGGHG TBC1D3D TNC RENBP TBC1D3C TBC1D3B FMN2 TBC1D3G TBC1D3K TBC1D3F | 1.31e-09 | 242 | 121 | 13 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TNC RENBP TBC1D3C TBC1D3B FMN2 TBC1D3G TBC1D3K TBC1D3F | 3.41e-09 | 213 | 121 | 12 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TNC RENBP TBC1D3C TBC1D3B FMN2 TBC1D3G TBC1D3K TBC1D3F | 3.41e-09 | 213 | 121 | 12 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | EPPK1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TNC TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 6.32e-07 | 281 | 121 | 11 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | EPPK1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TNC TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 6.32e-07 | 281 | 121 | 11 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L PGGHG TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 1.52e-05 | 320 | 121 | 10 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | SP3 DPYSL2 DPYSL3 MYLK ANK3 TNC LAMA4 KDM6B ANGPTL1 SPAG5 MFAP3 NRK SMARCC1 FMN2 EPHA4 | 5.50e-05 | 806 | 121 | 15 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | RAP1GAP STXBP4 LZTFL1 LAMA4 CNKSR2 FYCO1 ZFP69 ANGPTL1 KIF20B COL24A1 DGLUCY NRK ANKRD24 EPHA4 | 8.81e-05 | 744 | 121 | 14 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | RAP1GAP TBC1D3 TBC1D3H TBC1D3L TBC1D3D FCHO2 TBC1D3C TBC1D3B SPAG5 DGLUCY COG6 IQCJ-SCHIP1 AKAP1 TBC1D3G CDH5 TBC1D3K TBC1D3F | 9.44e-05 | 1049 | 121 | 17 | PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TSPOAP1 NUMA1 CNTNAP3 BTAF1 KDM6B TBC1D3C TBC1D3B IQCJ-SCHIP1 LTBP2 TBC1D3G TBC1D3K EPHA4 TBC1D3F | 1.27e-04 | 1075 | 121 | 17 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.76e-08 | 200 | 121 | 8 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.19e-07 | 175 | 121 | 7 | 9142ed8ca2f1c0c518deb21988221406f62fe38c | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.76e-07 | 182 | 121 | 7 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-07 | 184 | 121 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-07 | 184 | 121 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-07 | 184 | 121 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.02e-07 | 190 | 121 | 7 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.02e-07 | 190 | 121 | 7 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.34e-07 | 191 | 121 | 7 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.34e-07 | 191 | 121 | 7 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.04e-06 | 194 | 121 | 7 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.11e-06 | 196 | 121 | 7 | 481d79bdaec069ad2746a28d39eeee8d3edf7305 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.11e-06 | 196 | 121 | 7 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.15e-06 | 197 | 121 | 7 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-06 | 198 | 121 | 7 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.23e-06 | 199 | 121 | 7 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-06 | 199 | 121 | 7 | bd43a84e84d8acb8e1008b98a235cc5bd5f43586 | |
| ToppCell | Biopsy_Other_PF-Endothelial-Lymphatic_Endothelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.23e-06 | 199 | 121 | 7 | aa80c77fe4f6a141c780c7d8ecfff5d5a1c3b845 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.23e-06 | 199 | 121 | 7 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | ASK452-Endothelial|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.23e-06 | 199 | 121 | 7 | 0bc97a9a78aaafd1554ae6a61356ed9ea4983fa5 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-06 | 199 | 121 | 7 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-06 | 199 | 121 | 7 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | (5)_Fibroblasts|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.27e-06 | 200 | 121 | 7 | 22c839f27d3abdf86bfabdfa305f205dd899a9dc | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-06 | 200 | 121 | 7 | c5d818203bef80ff97c2e0158cf61970673dd258 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.27e-06 | 200 | 121 | 7 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.71e-06 | 176 | 121 | 6 | a8875b4ba4abf6625cdeb67bf544ce1573c59060 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.90e-06 | 180 | 121 | 6 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-05 | 181 | 121 | 6 | b244ecaa442bbef51289d8ec574ef08fa9e96318 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-05 | 181 | 121 | 6 | dd79de8098edb385a0f85d0e9621503cdf76ec43 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-05 | 181 | 121 | 6 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-05 | 182 | 121 | 6 | fd786c88826ad3d5cc5c3d80f8e392d6be1b5267 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.05e-05 | 182 | 121 | 6 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-05 | 183 | 121 | 6 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-05 | 184 | 121 | 6 | 453295362888c9a59d0e73c7a5b15914c50ff591 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-05 | 184 | 121 | 6 | 590fb32bb1f348ea5fa2aece30ebe1e212512991 | |
| ToppCell | Endothelial-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.16e-05 | 185 | 121 | 6 | ae49c61f6ecf128fe2a958b8c75c83688da75f59 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-05 | 185 | 121 | 6 | 0e0f043ad6d2a62cd47ce39911ad81feab4a4d7e | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-05 | 185 | 121 | 6 | 89b85ce8026dc80c1bd9f76dfe16401c173b7946 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-05 | 186 | 121 | 6 | 84ba666237c18189d7e7556bd92dd953af733c00 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-05 | 186 | 121 | 6 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.23e-05 | 187 | 121 | 6 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.23e-05 | 187 | 121 | 6 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 1.23e-05 | 187 | 121 | 6 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.23e-05 | 187 | 121 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-05 | 188 | 121 | 6 | 95d0a796d62ce6d121e2028c378faffc14b35275 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-05 | 188 | 121 | 6 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 1.31e-05 | 189 | 121 | 6 | c76d8af2e0aa4a83ee0c3439c894566fbf117dd3 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-05 | 189 | 121 | 6 | ab7ece0a517499b70b7754720d3e434765363af6 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.31e-05 | 189 | 121 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | COVID-19-lung-Lymphatic_EC|lung / Disease (COVID-19 only), tissue and cell type | 1.31e-05 | 189 | 121 | 6 | c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.35e-05 | 190 | 121 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 191 | 121 | 6 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 191 | 121 | 6 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-05 | 191 | 121 | 6 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.39e-05 | 191 | 121 | 6 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.39e-05 | 191 | 121 | 6 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | COVID-19-lung-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.43e-05 | 192 | 121 | 6 | cbe57cda44232b183821ac633b60a2668265e616 | |
| ToppCell | facs-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 192 | 121 | 6 | cca2d0fedfbd946c54d6f4fc45887117c8dae58a | |
| ToppCell | COPD-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 1.47e-05 | 193 | 121 | 6 | 25bdc557055b5bce6a21f8696b48e991c696b979 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.47e-05 | 193 | 121 | 6 | 5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-05 | 194 | 121 | 6 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-05 | 194 | 121 | 6 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | LAM-Endothelial|LAM / Condition, Lineage and Cell class | 1.51e-05 | 194 | 121 | 6 | 1241e3e75414b619abc9431627619f5c194ec930 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 1.56e-05 | 195 | 121 | 6 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | ASK440-Endothelial-Endothelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.56e-05 | 195 | 121 | 6 | 304f0dc91bb57e98b0ca31d6bfb3ff9364e4da56 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-05 | 195 | 121 | 6 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | ASK440-Endothelial|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.56e-05 | 195 | 121 | 6 | 1cdaab17866a1e5170e0f6bfcc69134425fdd8df | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-05 | 195 | 121 | 6 | 81a98ebb0d43f416f9a8bba580531dc0cfea8f74 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-05 | 195 | 121 | 6 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 1.61e-05 | 196 | 121 | 6 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | 3'-Adult-LymphNode-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.61e-05 | 196 | 121 | 6 | a2845436003e9adf34677eb81e78f8334ff01faa | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.61e-05 | 196 | 121 | 6 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-05 | 196 | 121 | 6 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 1.61e-05 | 196 | 121 | 6 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | PND07-Mesenchymal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.61e-05 | 196 | 121 | 6 | 0050c7134473fbfd7b9f0ae8d6d337713e60b57d | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.65e-05 | 197 | 121 | 6 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.65e-05 | 197 | 121 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.65e-05 | 197 | 121 | 6 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.65e-05 | 197 | 121 | 6 | f969685dee212f33a6f09e54c0cd1fd24ffef546 | |
| ToppCell | Fibroblast|World / shred by cell class for bronchial biopsy | 1.65e-05 | 197 | 121 | 6 | 8bf9846228b6b6721b10375fe54a2fb389ff64a6 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.65e-05 | 197 | 121 | 6 | 1a137af40697137bb9d2b5caf2b1ffda55f04461 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-05 | 197 | 121 | 6 | 16758f181ef07c60aee63072e1da9572c5c85414 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.65e-05 | 197 | 121 | 6 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | 356C-Endothelial_cells|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.65e-05 | 197 | 121 | 6 | f20eda534b2b28986790b28ce150ca3ba067593a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 197 | 121 | 6 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.65e-05 | 197 | 121 | 6 | 96d63a8d00583e2aa0a38412e2ae27e23f399493 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-05 | 198 | 121 | 6 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 1.70e-05 | 198 | 121 | 6 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | ILEUM-non-inflamed-(7)_ACKR1+_endothelial_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.70e-05 | 198 | 121 | 6 | f8a6a75c9f2fbe32a22b14b6a029411c73c09f68 | |
| ToppCell | 5'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.70e-05 | 198 | 121 | 6 | 90e85fe7a0ab376a41666dfff6c0e95b7f1c9475 | |
| ToppCell | Endothelial_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.70e-05 | 198 | 121 | 6 | b93effa428ec036542fa21647dfef9589c64640f | |
| ToppCell | E18.5-Mesenchymal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.70e-05 | 198 | 121 | 6 | a16aa41eab2e297e56de43c22c355df0f79315da | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.75e-05 | 199 | 121 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.75e-05 | 199 | 121 | 6 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | distal-1-mesenchymal-Myofibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.75e-05 | 199 | 121 | 6 | 58c36f5a30c6862b7f5587a0b9bc31da99e43dd5 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.75e-05 | 199 | 121 | 6 | cb3c04b91c8e8080137823b11c76ca0a2adda52d | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-05 | 199 | 121 | 6 | 212e89d097753790061310373a1fafba773488b6 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.75e-05 | 199 | 121 | 6 | 6a0df9a2f30480043f9c1d7fbdede17eb0910cac | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-05 | 199 | 121 | 6 | a843bdfcb58bec5e2a94a5ec9d5b8c5e4aef15d2 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-05 | 199 | 121 | 6 | 14b676aa289c0578a37be32cec3ea285c79d97cc | |
| Disease | macrophage inflammatory protein 1b measurement | 1.24e-05 | 136 | 110 | 6 | EFO_0008219 | |
| Disease | dihydropyrimidinase-related protein 3 measurement | 1.38e-05 | 2 | 110 | 2 | EFO_0802467 | |
| Disease | CCL4 measurement | 5.49e-05 | 20 | 110 | 3 | EFO_0004751 | |
| Disease | Colorectal Carcinoma | DPYSL2 ERCC6 PEG3 OBSCN CNKSR2 AKAP12 AKR1B10 MLH1 MMRN2 DNAH8 CDH5 | 6.46e-05 | 702 | 110 | 11 | C0009402 |
| Disease | pneumonia, COVID-19 | 6.70e-05 | 113 | 110 | 5 | EFO_0003106, MONDO_0100096 | |
| Disease | prostate carcinoma, breast carcinoma, ovarian carcinoma | 1.38e-04 | 27 | 110 | 3 | EFO_0000305, EFO_0001075, EFO_0001663 | |
| Disease | neuroimaging measurement | DPYSL2 DPYSL3 ANK3 PRSS12 DPYSL4 CNKSR2 XPO1 KIF20B CCDC88C COL24A1 IQCJ-SCHIP1 AGAP1 EPHA4 | 1.77e-04 | 1069 | 110 | 13 | EFO_0004346 |
| Disease | hydrocephalus (is_implicated_in) | 2.05e-04 | 6 | 110 | 2 | DOID:10908 (is_implicated_in) | |
| Disease | procollagen galactosyltransferase 1 measurement | 3.80e-04 | 8 | 110 | 2 | EFO_0801922 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 3.80e-04 | 8 | 110 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | thioredoxin domain-containing protein 12 measurement | 4.18e-04 | 39 | 110 | 3 | EFO_0008298 | |
| Disease | symmetrical dimethylarginine measurement | 4.87e-04 | 9 | 110 | 2 | EFO_0006523 | |
| Disease | Glaucoma | 4.87e-04 | 9 | 110 | 2 | C0017601 | |
| Disease | Cardiomyopathy, Familial Idiopathic | 8.70e-04 | 50 | 110 | 3 | C1449563 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.07e-03 | 206 | 110 | 5 | C0152013 | |
| Disease | hair color | 1.12e-03 | 311 | 110 | 6 | EFO_0003924 | |
| Disease | congenital heart disease | 1.41e-03 | 59 | 110 | 3 | EFO_0005207 | |
| Disease | cortical surface area measurement | TRPM6 DPYSL2 DPYSL3 ANK3 PRSS12 XPO1 FCHO2 KIF20B CCDC88C COL24A1 MLH1 AGAP1 EPHA4 | 1.51e-03 | 1345 | 110 | 13 | EFO_0010736 |
| Disease | p-cresol sulfate measurement | 1.60e-03 | 16 | 110 | 2 | EFO_0010998 | |
| Disease | red blood cell density measurement | STARD13 SP3 STXBP4 SPTA1 FCHO2 KDM6B KIF20B PLCL2 ARHGEF3 AGAP1 | 1.69e-03 | 880 | 110 | 10 | EFO_0007978 |
| Disease | C-X-C motif chemokine 16 measurement | 2.03e-03 | 18 | 110 | 2 | EFO_0010911 | |
| Disease | Nuclear non-senile cataract | 2.03e-03 | 18 | 110 | 2 | C1112705 | |
| Disease | Nuclear cataract | 2.03e-03 | 18 | 110 | 2 | C0392557 | |
| Disease | melanoma | 2.41e-03 | 248 | 110 | 5 | C0025202 | |
| Disease | COVID-19, osteoarthritis | 2.50e-03 | 20 | 110 | 2 | MONDO_0005178, MONDO_0100096 | |
| Disease | body weight | EHBP1 STXBP4 DPYSL4 CNKSR2 MFAP3 FASN STK39 LTBP2 SCRIB PATJ AGAP1 EPHA4 | 2.62e-03 | 1261 | 110 | 12 | EFO_0004338 |
| Disease | balding measurement | 2.88e-03 | 792 | 110 | 9 | EFO_0007825 | |
| Disease | cortical thickness | A2M EHBP1 DPYSL2 PRSS12 DPYSL4 KIF20B FMN2 TMEM131 IQCJ-SCHIP1 AGAP1 EPHA4 | 2.97e-03 | 1113 | 110 | 11 | EFO_0004840 |
| Disease | colorectal carcinoma (is_implicated_in) | 3.03e-03 | 22 | 110 | 2 | DOID:0080199 (is_implicated_in) | |
| Disease | Manic | 3.13e-03 | 78 | 110 | 3 | C0338831 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AQQVQIHQIGEDGQV | 376 | Q8N9N5 | |
| EDGQVQVGHLHIAQV | 386 | Q8N9N5 | |
| GINVDVIHAERTQQQ | 436 | Q9Y2R4 | |
| HDEQQVEAGAVQLRA | 36 | Q92667 | |
| EVIVVNQVNAGHLFV | 711 | Q92667 | |
| NVGVQVVHEHIEDGI | 356 | Q6P093 | |
| GQLHQVKINREEAVV | 1101 | Q9BZ76 | |
| AHQDRVEQIAAIAQE | 446 | P12814 | |
| VLQNQIREHVIAIED | 41 | Q9UPQ3 | |
| HLEEAINIIQGIVAE | 286 | Q9NR81 | |
| QQNVDVFAEDIHGIT | 226 | Q9BXX2 | |
| IVEIHEENEVASGTQ | 1191 | Q02952 | |
| IHEVNVQGTRNVIEA | 101 | Q9H2F3 | |
| QVHAENGDIIAQEQT | 196 | Q14195 | |
| EIHLQIGQVHEEFIN | 226 | Q0JRZ9 | |
| NEHEVGEAIQEKIQE | 51 | O60218 | |
| VLQLVVDVDGNIVNE | 101 | O95841 | |
| IAAQEGHIDVVQVLL | 1051 | Q9ULJ7 | |
| EHERIVGTLQANVAQ | 966 | Q8TF21 | |
| SIVQVHIEVLDENDN | 461 | P33151 | |
| EQGVLQQVDNAIHEA | 106 | Q03468 | |
| HTEAQIQEEGTVVEL | 321 | P01023 | |
| IQACVDHVNLVVQEE | 521 | P46940 | |
| GLDVVLDDNQNVHDV | 276 | Q6ZRI8 | |
| QAEAQREHEGAVQLL | 476 | O95153 | |
| QFIHQAVGIIEAVLE | 186 | Q68EN5 | |
| EQGVLQQVDNAIHEA | 106 | P0DP91 | |
| EIEEVSENVLQVHLN | 86 | O43929 | |
| QHVQRDGQAVLENVS | 226 | P51606 | |
| EEFEEEIGVQQIVIH | 701 | P56730 | |
| QIGALEEQLHQVRTE | 351 | Q7Z3Y7 | |
| QVLEIHGVNQDDVGV | 216 | Q15746 | |
| DIIINNQTGQHAVID | 281 | Q13572 | |
| EVLNGLQAVVHSEVE | 56 | Q9NQ48 | |
| IGISERQNAEQHVTQ | 171 | Q9NQS7 | |
| QVHAENGDIIAEEQQ | 196 | Q16555 | |
| GHLAAVINEVEVQQE | 161 | Q9H8L6 | |
| AQLEVHQGEVQRLQA | 776 | Q9BQS8 | |
| HQGEVQRLQAQVVDL | 781 | Q9BQS8 | |
| IRKEEEQQQHEAGVA | 706 | O15054 | |
| HVNEEEGVVAAVGQD | 321 | Q8NA75 | |
| QLDIETQAGIVAHIQ | 146 | Q9P219 | |
| EAVVHVNQEDLARIG | 941 | P54764 | |
| HVQNVIENIFEDVLE | 5676 | Q5CZC0 | |
| EAIRQQVEAVLAGHE | 111 | Q16549 | |
| LVAVDGENLEQVTHQ | 911 | Q9H5P4 | |
| AELQNAVAHQVQIEG | 2086 | Q96JB1 | |
| KNVTLDVQIQHVVEG | 1131 | Q96Q89 | |
| IQAQIGALEEQLHQV | 346 | Q7Z3Y8 | |
| IQAQIGALEEQLHQV | 341 | Q7Z3Z0 | |
| LDIVQELIAQGADVH | 121 | Q8WVL7 | |
| QEVHVNGAVVLAFEL | 366 | Q32M88 | |
| QDQVVIIDEAHNLID | 386 | Q96FC9 | |
| AQEVEANVHVPQVVL | 1371 | Q9GZU2 | |
| EVNGENVEKETHQQV | 61 | O14745 | |
| NEQGQEIAVQVSVHL | 306 | P55082 | |
| EDQQGGHQLIITAVV | 5176 | Q5VST9 | |
| QGVEENIQEVVGHIT | 336 | Q9Y2V7 | |
| LGQIELVQQQHVEDE | 921 | Q9P2D7 | |
| QVHAENGDIVEEEQK | 196 | O14531 | |
| VQHEEFILLSQGEVE | 166 | Q53G59 | |
| ADVHIEVGNRVNNNV | 786 | O14981 | |
| QVEHLQAAVVEARAQ | 1356 | Q9BV73 | |
| QTIQVDHQQAEVFIV | 216 | Q7Z7H3 | |
| DHQQAEVFIVEQTVH | 221 | Q7Z7H3 | |
| NVAEVLVNQGAHVDA | 711 | Q12955 | |
| HFSGQELNVVQIEEN | 546 | Q8NDI1 | |
| VIAQENLGAHIEKEQ | 106 | Q5I0G3 | |
| VQIHQVAQVRGGVEE | 486 | Q14767 | |
| QQIVNLIEETGHFNV | 516 | Q03111 | |
| NLHQKIVEDAVEQGV | 381 | Q7Z3D6 | |
| EAAQAELQQHDVAQG | 1281 | P49327 | |
| VEFRNGQLVVDNHEI | 131 | O14556 | |
| DIQHAVVNLDNSVVD | 1381 | Q9NZ56 | |
| GQLHQVKINREEAVV | 1101 | Q96NU0 | |
| QAVHDNQILIVIGET | 576 | Q14562 | |
| LQQLGEAHQAETEVL | 771 | Q14980 | |
| NVVQLDVDSEVNHVV | 1741 | Q16363 | |
| IRHENAVQGSAVEVQ | 281 | Q96A47 | |
| NDEVFHSIQAEVQIE | 756 | Q7Z2Y5 | |
| LDDILQHVNGLQEVV | 486 | Q9Y3M8 | |
| AQGVHRVDVFTDQVE | 161 | Q9BZY9 | |
| ADQENQVAHLELGQV | 806 | Q96R06 | |
| IHEQGDVIDSIEANV | 196 | O15400 | |
| IEANVENAEVHVQQA | 206 | O15400 | |
| IQHELRAQAQVEEAE | 216 | Q8TDN2 | |
| FLEAEQGVAHINEEI | 366 | Q9UPR0 | |
| QGVAHINEEISLEII | 371 | Q9UPR0 | |
| ELHEQLLVAEQAVTG | 351 | P58107 | |
| RHIGNDIVAVVFQDE | 286 | P47736 | |
| GLDVDSLVIEHIQVN | 106 | P18621 | |
| VNGQDVRDATHQEAV | 1061 | Q14160 | |
| QERQVEHLEQQVGQL | 416 | P07476 | |
| GQLQVIVNDLHSQIE | 501 | B3KU38 | |
| TVQGLQDQQEHVVAT | 231 | B9A6J9 | |
| VLSLQEEINEQGHEV | 506 | P40692 | |
| LQLDEVNVGAHEISN | 266 | Q6ZWJ1 | |
| DLGEDNVTEQTNHII | 436 | Q92922 | |
| IEVNNENVVKVGHRQ | 686 | Q9UPX8 | |
| GHQDVKDVQFAVEQV | 556 | P13798 | |
| GDVALQQLVHLEQAV | 931 | Q15021 | |
| IHAGDEVIQVNHQTV | 256 | Q8WXI2 | |
| AGVVVHAQEQGIDIL | 31 | Q17RW2 | |
| TVQGLQDQQEHVVAT | 231 | A6NDS4 | |
| TVQGLQDQQEHVVAT | 231 | P0C7X1 | |
| IGAQTDQTVQEHLIE | 641 | O14980 | |
| EQDIQTEVLVHLTGQ | 1376 | Q9BX84 | |
| TVQGLQDQQEHVVAT | 231 | A6NER0 | |
| HIQVNDKIVAVDGVN | 411 | Q8NI35 | |
| NHDVVEVLRNAGQVV | 431 | Q8NI35 | |
| QQEAEIDSIHQLVVG | 276 | Q9P2W9 | |
| LRVQVVDEEGDQQHQ | 576 | Q02447 | |
| VENTGQLQIHIETIE | 1021 | Q92545 | |
| FTIQVQEADQVEEAH | 1286 | P24821 | |
| TVQGLQDQQEHVVAT | 231 | A0A087X179 | |
| GQEEIQLRLAQFVEH | 1786 | P02549 | |
| RHEQQQLLGVEEVTD | 76 | Q96JH7 | |
| TVQGLQDQQEHVVAT | 231 | A0A087WVF3 | |
| LVDGHDVVIVAANLQ | 491 | Q9UEW8 | |
| TVQGLQDQQEHVVAT | 231 | Q6DHY5 | |
| TVQGLQDQQEHVVAT | 231 | Q8IZP1 | |
| VQEVLNGTEVNLQHL | 346 | Q9C0H2 | |
| QNTGILQDEILIHEE | 521 | Q6S545 | |
| VVNVDIQDNHEEATL | 136 | Q9NP77 | |
| TVQGLQDQQEHVVAT | 231 | A0A087X1G2 | |
| TVQGLQDQQEHVVAT | 231 | A0A087WXS9 | |
| TVQGLQDQQEHVVAT | 231 | Q6IPX1 | |
| FGENIIVHSNVIIEQ | 226 | Q49AA0 | |
| AVAELLENVGQVNEH | 196 | O76024 | |
| EVAQQAVDADVHAVG | 656 | P22033 | |
| QVQVAEEGLQDFHRA | 301 | Q96P71 |